Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 28, 2021; 27(28): 4710-4721
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4710
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4710
Table 1 Gastroesophageal reflux disease-Q scale scoring changes
Treatment, n = 116 | Control, n = 130 | Mean difference (95% confidence interval) | P value | |
Before treatment | 10.53 ± 2.01 | 10.10 ± 1.64 | 0.434 (0.067 to 0.077) | 0.077 |
2 wk treatment | 8.25 ± 1.85a | 7.99 ± 1.85a | 0.266 (0.100 to 0.112) | 0.108 |
4 wk treatment | 7.36 ± 1.71a | 7.21 ± 1.63a | 0.147 (0.463 to 0.483) | 0.469 |
1 mo withdrawal | 7.59 ± 1.82a | 7.59 ± 1.47a | 0.003 (0.301 to 0.309) | 0.301 |
3 mo withdrawal | 7.56 ± 1.78a | 7.44 ± 1.54a | 0.114 (0.826 to 0.841) | 0.837 |
- Citation: Li Z, Tao L, Zhang SS, Sun XH, Chen SN, Wu J. Modified Xiaochaihu Decoction for gastroesophageal reflux disease: A randomized double-simulation controlled trial. World J Gastroenterol 2021; 27(28): 4710-4721
- URL: https://www.wjgnet.com/1007-9327/full/v27/i28/4710.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i28.4710